Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprepitant for Prevention of Postoperative Nausea and Vomiting
NCT00090155Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Sep 2003
- Primary completion
- Nov 2004
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of aprepitant in postoperative nausea and vomiting (PONV), sponsored by Merck & Co.. Started Sep 2003; status: completed.
02
Drugs
aprepitant
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT00090155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00090155.